A sensitive and specific method for the quantitative determination of a new antitumor agent, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-l-nitrosourea, (PCNU) has been developed for the analysis of ,plasma. This assay involves extraction of the plasma sample, separation of the drug by thin-layer chr
β¦ LIBER β¦
The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea
β Scribed by B. Drewinko; L. -Y. Yang
- Book ID
- 104665387
- Publisher
- Springer US
- Year
- 1983
- Tongue
- English
- Weight
- 403 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Determination of 1-(2-chloroethyl)-3-(2,
β
Ronald G. Smith; Lily K. Cheung; Lynn G. Feun; Ti Li Loo
π
Article
π
1983
π
John Wiley and Sons
π
English
β 353 KB
Phase II trial of 1-(2-chloroethyl)-3-(2
π
Article
π
1985
π
Elsevier Science
π
English
β 96 KB
A phase II trial of 1-(2-chloroethyl)-3-
β
Lynn G. Feun; David J. Stewart; Milam E. Leavens; M. Andrew Burgess; Niramol Sav
π
Article
π
1983
π
Springer US
π
English
β 264 KB
Twenty-nine with patients recurrent primary malignant brain tumors were treated with 1-(2-chlorethyl)-3-(2,6-dioxo-3-piperidyl)-l-nitrosourea (PCNU) at an initial dose of 110 mg/m 2 with subsequent doses determined by the degree of delayed toxicity. The interval between treatments was usually weeks.
Inhibition of human glutathione reductas
β
P. Andrew KARPLUS; R. Luise KRAUTH-SIEGEL; R. Heiner SCHIRMER; Georg E. SCHULZ
π
Article
π
1988
π
John Wiley and Sons
π
English
β 592 KB
Induction of specific-locus and dominant
β
U.H. Ehling; I.-D. Adler; J. Favor; A. NeuhΓ€user-Klaus
π
Article
π
1997
π
Elsevier Science
π
English
β 314 KB
Alkylating Activity of 1,3-Bis(2-chloroe
β
Wheeler, Glynn P.; Chumley, Sue.
π
Article
π
1967
π
American Chemical Society
π
English
β 343 KB